ArticleClinical rheumatology2019

Second-line treatment with lesinurad and allopurinol versus febuxostat for management of hyperuricemia: a cost-effectiveness analysis for Spanish patients.

María Presa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.